这项研究得到了美国静脉论坛 （AVF） 2023 年基础科学研究资助和 Surmodics， Inc. 的支持。

以下协议遵循密歇根大学 （UMICH） 机构动物护理和使用委员会 （IACUC） 政策和指南、美国政府用于测试、研究和培训的脊椎动物利用和护理原则以及 ARRIVE 指南 2.0。UMICH 动物福利保证协议符合 OLAW 和 USDA，并获得了 AAALAC International 的全面认可。该实验方案的 ID 号为 PRO00010841。使用来自 Charles River Laboratories 的雄性远交 Sprague Dawley 大鼠，体重 450 克，年龄为 15 周龄。
1. 大...

用于深静脉治疗研究的啮齿动物静脉成形术球囊模型

<ol>
	<li>Prandoni, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+long-term+clinical+course+of+acute+deep+venous+thrombosis.">The long-term clinical course of acute deep venous thrombosis.</a> Ann Inter Med. 125 (1), 1-7 (1996).</li><li>Prandoni, P., Kahn, S. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Post-thrombotic+syndrome:+prevalence,+prognostication+and+need+for+progress.">Post-thrombotic syndrome: prevalence, prognostication and need for progress.</a> Br J Haematol. 145 (3), 286-295 (2009).</li><li>Gloviczki, P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+2023+Society+for+Vascular+Surgery,+American+Venous+Forum,+and+American+Vein+and+Lymphatic+Society+clinical+practice+guidelines+for+the+management+of+varicose+veins+of+the+lower+extremities.+Part+II.">The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II.</a> J Vas Surg Venous Lymph Diso. 12 (1), 101670 (2024).</li><li>Henke, P., Sharma, S., Wakefield, T., Myers, D., Obi, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Insights+from+experimental+post-thrombotic+syndrome+and+potential+for+novel+therapies.">Insights from experimental post-thrombotic syndrome and potential for novel therapies.</a> Transl Res. 225, 95-104 (2020).</li><li>Diaz, J. A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Choosing+a+mouse+model+of+venous+thrombosis:+A+consensus+assessment+of+utility+and+application.">Choosing a mouse model of venous thrombosis: A consensus assessment of utility and application.</a> Arterioscl Thrombo Vasc Biol. 39 (3), 311-318 (2019).</li><li>Lee, Y. U., Lee, A. Y., Humphrey, J. D., Rausch, M. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Histological+and+biomechanical+changes+in+a+mouse+model+of+venous+thrombus+remodeling.">Histological and biomechanical changes in a mouse model of venous thrombus remodeling.</a> Biorheology. 52 (3), 235-245 (2015).</li><li>Xie, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Correspondence+of+ultrasound+elasticity+imaging+to+direct+mechanical+measurement+in+aging+DVT+in+rats.">Correspondence of ultrasound elasticity imaging to direct mechanical measurement in aging DVT in rats.</a> Ultrasound Med Biol. 31 (10), 1351-1359 (2005).</li><li>Moini, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Venoplasty+and+stenting+in+post-thrombotic+syndrome+and+non-thrombotic+iliac+vein+lesion.">Venoplasty and stenting in post-thrombotic syndrome and non-thrombotic iliac vein lesion.</a> Minim Invasive Ther Allied Technol. 29 (1), 35-41 (2020).</li><li>Chaitidis, N., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Management+of+post-thrombotic+syndrome:+A+comprehensive+review.">Management of post-thrombotic syndrome: A comprehensive review.</a> Curr Pharma Des. 28 (7), 550-559 (2022).</li><li>Dangas, G. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In-stent+restenosis+in+the+drug-eluting+stent+era.">In-stent restenosis in the drug-eluting stent era.</a> J Am Coll Cardiol. 56 (23), 1897-1907 (2010).</li><li>Negl&#233;n, P., Berry, M. A., Raju, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Endovascular+surgery+in+the+treatment+of+chronic+primary+and+post-thrombotic+iliac+vein+obstruction.">Endovascular surgery in the treatment of chronic primary and post-thrombotic iliac vein obstruction.</a> Euro J Vas Endovas Surg. 20 (6), 560-571 (2000).</li><li>Sharifi, M., Mehdipour, M., Bay, C., Smith, G., Sharifi, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Endovenous+therapy+for+deep+venous+thrombosis:+The+TORPEDO+trial.">Endovenous therapy for deep venous thrombosis: The TORPEDO trial.</a> Catheter Cardiovasc Interv. 76 (3), 316-325 (2010).</li><li>Nicklas, J. M., Gordon, A. E., Henke, P. K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Resolution+of+deep+venous+thrombosis:+Proposed+immune+paradigms.">Resolution of deep venous thrombosis: Proposed immune paradigms.</a> Int J Mol Sci. 21 (6), 2080 (2020).</li><li>Li, J., Kim, S. G., Blenis, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapamycin:+One+drug,+many+effects.">Rapamycin: One drug, many effects.</a> Cell Metabol. 19 (3), 373-379 (2014).</li><li>Chen, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapamycin+regulates+Akt+and+ERK+phosphorylation+through+mTORC1+and+mTORC2+signaling+pathways.">Rapamycin regulates Akt and ERK phosphorylation through mTORC1 and mTORC2 signaling pathways.</a> Mol Carcinogen. 49 (6), 603-610 (2010).</li><li>Diaz, J. A., Farris, D. M., Wrobleski, S. K., Myers, D. D., Wakefield, T. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inferior+vena+cava+branch+variations+in+C57BL/6+mice+have+an+impact+on+thrombus+size+in+an+IVC+ligation+(stasis)+model.">Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) model.</a> J Thromb Haemo. 13 (4), 660-664 (2015).</li><li>Sch&#246;nfelder, T., J&#228;ckel, S., Wenzel, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mouse+models+of+deep+vein+thrombosis.">Mouse models of deep vein thrombosis.</a> Gef&#228;sschirurgie. 22 (1), 28-33 (2017).</li><li>de Barros, R. S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Morphometric+analysis+of+rat+femoral+vessels+under+a+video+magnification+system.">Morphometric analysis of rat femoral vessels under a video magnification system.</a> J Vasc Bras. 16 (1), 73-76 (2017).</li></ol>

没有宣布利益冲突。

可以使用 2.5-3.5 mm 范围内的球囊对 250 g ≥大鼠进行 VBM。对于超过 750 g 的大鼠，该技术受到腹腔中脂肪组织数量和器官大小的限制，而不是 IVC 直径的变化。根据我们的经验，我们发现每组需要 10 只或更多动物才能获得组间的统计学显着性，以进行静脉壁蛋白分析或活性测定和组织学。手术干预期间的定期温度控制和呼吸频率监测对于保证手术成功以及勤奋的术后管理非常重要。
<p class="jove_co...

未解决的血栓引起的深静脉阻塞是深静脉血栓形成 （DVT） 的常见后果，是血栓形成后综合征 （PTS） 的原因之一，花费数十亿美元的医疗保健费用并显着影响生活质量 1,2,3。PTS 是一种独特的炎症病理学，随之而来的静脉壁纤维化4 在小动物 DVT 模型中未完全捕获 5,6,7，更重要的是，以前的模型无法评估对治疗干预的反应。血栓性静脉阻塞通常通过支架置入术和球囊静脉成形术来治疗 8,9;由于再狭窄和闭塞，这种干预受到高再干预率的阻碍 10,11,12。
尽管有药物涂层球囊可以解决动脉特异性狭窄/闭塞，但不存在用于深静脉的球囊。静脉再狭窄背后的分子机制知之甚少，也没有直接的治疗方法4。因此，我们的目标是提出一种动物模型，该模型可以通过模拟血栓后深静脉阻塞的静脉成形球囊测试局部给药的治疗。该模型再现了血栓形成后的情况，并评估了不同类型的静脉成形球囊如何影响 体内静脉壁。

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>3-0 DemeCRYL</td>
			<td>DemeTech</td>
			<td>G183019F4P</td>
			<td>12 per box</td>
		</tr>
		<tr>
			<td>5-0 DemeCRYL</td>
			<td>DemeTech</td>
			<td>G285017B0P</td>
			<td>12 per box</td>
		</tr>
		<tr>
			<td>7-0 DemeLENE</td>
			<td>DemeTech</td>
			<td>PM197011F13M</td>
			<td>12 per box</td>
		</tr>
		<tr>
			<td>8-0 DemeLON</td>
			<td>DemeTech</td>
			<td>NL868007C7P</td>
			<td>12 per box</td>
		</tr>
		<tr>
			<td>Angled Clip Applier</td>
			<td>SCANLAN</td>
			<td>3795-01A</td>
			<td>7-1/4&#8243; (18.5 cm)</td>
		</tr>
		<tr>
			<td>Baxter 0.9% Sodium Chloride Irrigation Bottle</td>
			<td>Baxter</td>
			<td>SKU: 195-7124</td>
			<td>1000mL Bottle</td>
		</tr>
		<tr>
			<td>Bovie Cautery Low Temperature Fine Tip</td>
			<td>Symmetry Surgical Inc</td>
			<td>AA00</td>
			<td>10/bx</td>
		</tr>
		<tr>
			<td>Buprenorphine</td>
			<td>Fidelis Animal Health</td>
			<td>SKU- 099114</td>
			<td>1.3mg/mL, 3mL</td>
		</tr>
		<tr>
			<td>CD (Sprague Dawley) Rats</td>
			<td>Charles River</td>
			<td>Strain Code 001</td>
			<td>Male, 400 gm</td>
		</tr>
		<tr>
			<td>Clip-It Traceable Timer</td>
			<td>TRACEABLE PRODUCTS</td>
			<td>Cat. No. 5046</td>
			<td></td>
		</tr>
		<tr>
			<td>Cotton-Tip Applicator 3&#34;</td>
			<td>Dukal Corporation</td>
			<td>922-00037BX100</td>
			<td>1000/BOX</td>
		</tr>
		<tr>
			<td>Enzymatic Surgical Instrument Detergent and Presoak</td>
			<td>Medline</td>
			<td>MDS88000B9</td>
			<td>1 Gal</td>
		</tr>
		<tr>
			<td>Eye Lube</td>
			<td>Optixcare</td>
			<td>SKU-065441</td>
			<td>20gm&#160;</td>
		</tr>
		<tr>
			<td>Gaymar T/Pump Stryker Localized Warming/Cooling Therapy System</td>
			<td>Stryker</td>
			<td>TP700</td>
			<td></td>
		</tr>
		<tr>
			<td>Heifetz Microclips 12mmx2.25mm</td>
			<td>SCANLAN</td>
			<td>3795-20</td>
			<td>Straight</td>
		</tr>
		<tr>
			<td>Heifetz Microclips 12mmx2.25mm</td>
			<td>SCANLAN</td>
			<td>3795-28</td>
			<td>Curved</td>
		</tr>
		<tr>
			<td>Heifetz Microclips 8mmx1.75mm&#160;</td>
			<td>SCANLAN</td>
			<td>3795-14</td>
			<td>Straight</td>
		</tr>
		<tr>
			<td>Heifetz Microclips 8mmx1.75mm&#160;</td>
			<td>SCANLAN</td>
			<td>3795-18</td>
			<td>Curved</td>
		</tr>
		<tr>
			<td>Inflation device&#160;</td>
			<td>Merit Medical</td>
			<td>IN4130</td>
			<td>BasixCOMPAK with Analog Display</td>
		</tr>
		<tr>
			<td>Isoflurane</td>
			<td>MFR VETONE</td>
			<td>SKU-501017</td>
			<td>100mL, Liquid for Inhalation</td>
		</tr>
		<tr>
			<td>Microsurgery kit containing tweezers and forceps</td>
			<td>Customized</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Oxygen, E-tank</td>
			<td>Medline</td>
			<td>MDM1630</td>
			<td></td>
		</tr>
		<tr>
			<td>Sharpened Guidewire</td>
			<td>Customized</td>
			<td></td>
			<td></td>
		</tr>
		<tr>
			<td>Sterile Glad Press-n-Seal</td>
			<td>Glad</td>
			<td>SKU # PSS-140</td>
			<td>ETO Exposed</td>
		</tr>
		<tr>
			<td>Sterile Nonwoven Gauze Sponges 2s 4ply 4x4&#160;</td>
			<td>Medline</td>
			<td>SKU PRM21444H</td>
			<td>100Ct</td>
		</tr>
		<tr>
			<td>Surgical microscope&#160;</td>
			<td>Zeiss</td>
			<td>S100 / OPMI pico</td>
			<td></td>
		</tr>
		<tr>
			<td>Surgical Scrub &#38; Handwash</td>
			<td>Vetoquinol</td>
			<td>NDC: 17030-003-16</td>
			<td>16 oz</td>
		</tr>
		<tr>
			<td>Ultrasound Gel</td>
			<td>Medline</td>
			<td>CTR001305</td>
			<td>8.5 oz, 12/CS</td>
		</tr>
		<tr>
			<td>Ultrasound system</td>
			<td>Siemens</td>
			<td>ACUSON Antares</td>
			<td>3-D, Color, Continuous wave (CW), Pulsed wave (PW), Power CW/CW Spectral</td>
		</tr>
		<tr>
			<td>Venoplasty Balloon</td>
			<td>Customized</td>
			<td></td>
			<td></td>
		</tr>
	</tbody>
</table>

rodent inferior vena cava venoplasty balloon model

球囊静脉成形术是一种常用的临床技术，用于治疗因外伤、先天性解剖异常、急性深静脉血栓形成 （DVT） 或支架置入术而导致的深静脉狭窄和闭塞。慢性深静脉阻塞的组织病理学特征为血栓形成、纤维化或两者兼而有之。目前，没有针对这些病理过程的直接治疗方法。因此，需要一个可靠的 体内 动物模型来测试新的干预措施。啮齿动物存活下腔静脉 （IVC） 静脉成形术球囊模型 （VBM） 允许在多个时间点研究非血栓形成和血栓形成后条件下的球囊静脉成形术。涂层和非涂层静脉成形术球囊的局部和全身效应可以通过组织、血栓和血液测定进行量化，例如实时聚合酶链反应 （RT-PCR）、蛋白质印迹、酶联免疫吸附测定 （ELISA）、酶谱、静脉壁和血栓细胞分析、全血和血浆测定以及组织学分析。VBM 是可重复的，可复制手术人工干预，可以识别局部静脉壁血栓蛋白变化，并允许对同一样品进行多次分析，从而减少每组所需的动物数量。

Deep vein obstructions from unresolved thrombi are a common consequence of deep vein thrombosis (DVT) and are one of the causes of post-thrombotic syndrome (PTS), costing billions of dollars in healthcare and significantly impacting the quality of life1,2,3. PTS is a unique inflammatory pathology with consequent vein wall fibrosis4 not fully captured in small animal DVT models5,6,7, and more importantly, previous models cannot evaluate the response to therapeutic interventions. Thrombotic venous obstructions are often treated by stenting and balloon venoplasty8,9; such interventions are hampered by a high reintervention rate due to restenosis and occlusion10,11,12.
Despite the availability of drug-coated balloons to address arterial-specific stenosis/occlusions, none exist for deep veins. The molecular mechanism behind restenosis is poorly understood in veins and has no direct therapy4. Therefore, our goal is to present an animal model that can test locally delivered therapeutics via venoplasty balloons simulating deep vein post-thrombotic obstructions. This model reproduces the post-thrombotic condition and evaluates how different types of venoplasty balloons affect the vein wall in vivo.

作者聚焦：在啮齿动物中利用静脉成形术球囊模型模拟深静脉的手术干预

啮齿动物下腔静脉成形术球囊模型

In our laboratory, led by Dr.Andrea Obi, we study a type of abnormal blood clotting, venous thrombosis. In fact, we're one of the very few laboratories in the world working in this promising discovery area. Our goal is to take our findings and translate them into new, safer, more effective approaches to treat venous thrombosis.Our work has led us to look more closely at the role of the immune system, including the presence of infection in thrombus formation, as well as the pathways leading to clot resolution, venous fibrosis, including vein wall scarring and post-thrombotic syndrome. No previous animal model has been able to replicate the complex immune interactions that occur in venous thromboembolism in humans. Additionally, no model has been able to characterize the response to endovascular treatments followed by ultrasound.We are making important contributions to understand how different types of immune cells interact with environment around a blood clot, and how those interactions can lead to changes in the expression of cell's genetics code, a process now as epigenetic regulation. We believe that Inferior Vena Cava Venoplasty Balloon Model will accelerate the development of novel balloon angioplasty prototypes for the treatment of venous thrombosis, and the possibility for prevention of post-thrombotic syndrome.

VBM 是一种评估静脉成形术球囊在完全止血控制中效果的模型。首先，我们量化了 IVC （肾下中段） 直径，如图 1 所示，用于正确的球囊尺寸。其次，开发的分步显微外科技术如图 2 所示，我们还展示了 图 3 中关键步骤的示例。请注意用于 IVC 插管的逆行方法，使用锋利的导丝。
<p class="jove_content biglegend" fo:keep-together.within-page="...

该方案提出了一个存活啮齿动物模型，用于测试静脉成形球囊 （VB） 干预在非血栓形成、血栓形成和血栓形成后深静脉中的应用。

Balloon venoplasty is a commonly used clinical technique to treat deep vein stenosis and occlusion as a consequence of trauma, congenital anatomic ...

rodent-inferior-vena-cava-venoplasty-balloon-model

Research

JoVE Journal

Medicine

Rodent Inferior Vena Cava Venoplasty Balloon Model

327 Views.  University of Michigan. In our laboratory, led by Dr.Andrea Obi, we study a type of abnormal blood clotting, venous thrombosis. In fact, we're one of the very few laboratories in the world working in this promising discovery area. Our goal is to take our findings and translate them into new, safer, more effective approaches to treat venous thrombosis.Our work has led us to look more closely at the role of the immune system, including the presence of infection in thrombus formation, as well as the pathways lea...